Comparison · NCT03660488-c09ff18e
Benzathine Penicillin G vs Cefixime Group: Treatment Response
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Benzathine Penicillin G vs Cefixime Group: Treatment Response. Trial comparisons, record NCT03660488-c09ff18e. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03660488-c09ff18e
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.933 | 0.702 | 0.988 | wilson | |
| Risk in group 2 | 0.867 | 0.621 | 0.963 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0667 | -0.184 | 0.318 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.08 | 0.847 | 1.37 | log | |
| Odds ratio, group 1 over group 2 | 2.15 | 0.174 | 26.7 | log | |
| Number needed to treat, for one more participant with the outcome on Benzathine Penicillin G than on Cefixime Group | 15 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Benzathine Penicillin G | Patients of the Penicillin Group will receive the standard of care treatment. This is one intramuscular injection of 2.4 million units Benzathine Penicillin G. The group will consist of 50 patients.~Benzathine Penicillin G: The control group will receive Benzathine Penicillin G 2.4 Million Units intramuscularly for treatment of syphilis. Penicillin is the indicated treatment for syphilis infection | 14 | 15 | OG000 |
| Group 2 | Cefixime Group | Patients of the Cefixime Group will receive Cefixime 400 mg, per os, one tablet, two times per day, for ten consecutive days. The study team will provide the medication.~The group will consist of 50 patients.~Cefixime 400 milligram Oral Capsule \[Suprax\]: The intervention group will receive Cefixime 400mg, one tablet twice per day, for ten consecutive days | 13 | 15 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Treatment Response
- Description
- subjects who have a 4-fold decrease (from study entry Rapid plasma reagin) in Rapid plasma reagintiters from baseline at 3 or 6 months will be considered a positive treatment response.
- Time frame
- 3 or 6 months after treatment completion
- Population
Source ClinicalTrials.gov
Trial
- Title
- Cefixime for Alternative Syphilis Treatment
- NCT number
- NCT03660488
- Phases
- PHASE2
- Conditions
- Syphilis, Early Syphilis
- Interventions
- Cefixime 400 milligram Oral Capsule [Suprax], Benzathine Penicillin G
- Lead sponsor
- University of California, Los Angeles
- Results first posted
- 2022-07-26
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03660488?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03660488-c09ff18e